BACKGROUND: Particulate matter (PM) exposure has been linked to increased risk of cardiovascular disease, possibly resulting from hypercoagulability and thrombosis. Lung and systemic inflammation resulting from PM inhalation may activate blood coagulation, but mechanisms for PM-related hypercoagulability are still largely unknown. OBJECTIVES: To identify coagulation mechanisms activated by PM in a population with well-characterized exposure. METHODS: We measured prothrombin time (PT), activated partial thromboplastin time, endogenous thrombin potentials (ETPs) with/without exogenous triggers and with/without soluble thrombomodulin, tissue-type plasminogen activator (t-PA) antigen, D-dimer and C-reactive protein (CRP) in 37 workers in a steel production plant with well-characterized exposure to PM with aerodynamic diameter of < 1 mum (PM(1)) and coarse PM (PM(10) - PM(1)). Blood samples were collected from each subject on the first (baseline) and last (postexposure) day of a 4-day work week. We analyzed differences between baseline and postexposure levels using a paired Student's t-test. We fitted multivariate mixed-regression models to estimate the associations of interquartile range PM(1) and coarse PM exposure with parameter levels. RESULTS: None of the parameters showed any significant changes from baseline in postexposure samples. However, exposure levels were associated with shorter PT (beta[PM(1)] = -0.33 s, P = 0.08; beta[PM(coarse)] = - 0.33 s, P = 0.01), and higher ETP without exogenous triggers and with thrombomodulin (beta[PM(1)] = + 99 nm min, P = 0.02; beta[PM(coarse)] = + 66 nm min, P = 0.05), t-PA (beta[PM(1)] = + 0.72 ng mL(-1), P = 0.01; beta[PM(coarse)] = + 0.88 ng mL(-1), P = 0.04), and CRP (beta[PM(1)] = + 0.59 mg L(-1), P = 0.03; beta[PM(coarse)] = + 0.48 mg L(-1), P = 0.01). CONCLUSIONS: PM exposure did not show any short-term effect within the week of the study. The association of PM exposure with PT, ETP and CRP provides some evidence of long-term effects on inflammation and coagulation.
BACKGROUND: Particulate matter (PM) exposure has been linked to increased risk of cardiovascular disease, possibly resulting from hypercoagulability and thrombosis. Lung and systemic inflammation resulting from PM inhalation may activate blood coagulation, but mechanisms for PM-related hypercoagulability are still largely unknown. OBJECTIVES: To identify coagulation mechanisms activated by PM in a population with well-characterized exposure. METHODS: We measured prothrombin time (PT), activated partial thromboplastin time, endogenous thrombin potentials (ETPs) with/without exogenous triggers and with/without soluble thrombomodulin, tissue-type plasminogen activator (t-PA) antigen, D-dimer and C-reactive protein (CRP) in 37 workers in a steel production plant with well-characterized exposure to PM with aerodynamic diameter of < 1 mum (PM(1)) and coarse PM (PM(10) - PM(1)). Blood samples were collected from each subject on the first (baseline) and last (postexposure) day of a 4-day work week. We analyzed differences between baseline and postexposure levels using a paired Student's t-test. We fitted multivariate mixed-regression models to estimate the associations of interquartile range PM(1) and coarse PM exposure with parameter levels. RESULTS: None of the parameters showed any significant changes from baseline in postexposure samples. However, exposure levels were associated with shorter PT (beta[PM(1)] = -0.33 s, P = 0.08; beta[PM(coarse)] = - 0.33 s, P = 0.01), and higher ETP without exogenous triggers and with thrombomodulin (beta[PM(1)] = + 99 nm min, P = 0.02; beta[PM(coarse)] = + 66 nm min, P = 0.05), t-PA (beta[PM(1)] = + 0.72 ng mL(-1), P = 0.01; beta[PM(coarse)] = + 0.88 ng mL(-1), P = 0.04), and CRP (beta[PM(1)] = + 0.59 mg L(-1), P = 0.03; beta[PM(coarse)] = + 0.48 mg L(-1), P = 0.01). CONCLUSIONS:PM exposure did not show any short-term effect within the week of the study. The association of PM exposure with PT, ETP and CRP provides some evidence of long-term effects on inflammation and coagulation.
Authors: S Wielders; M Mukherjee; J Michiels; D T Rijkers; J P Cambus; R W Knebel; V Kakkar; H C Hemker; S Béguin Journal: Thromb Haemost Date: 1997-04 Impact factor: 5.249
Authors: D W Dockery; C A Pope; X Xu; J D Spengler; J H Ware; M E Fay; B G Ferris; F E Speizer Journal: N Engl J Med Date: 1993-12-09 Impact factor: 91.245
Authors: Mark W Frampton; Mark J Utell; Wojciech Zareba; Günter Oberdörster; Christopher Cox; Li-Shan Huang; Paul E Morrow; F Eun-Hyung Lee; David Chalupa; Lauren M Frasier; Donna M Speers; Judith Stewart Journal: Res Rep Health Eff Inst Date: 2004-12
Authors: Andrea Baccarelli; Ida Martinelli; Antonella Zanobetti; Paolo Grillo; Li-Fang Hou; Pier A Bertazzi; Pier Mannuccio Mannucci; Joel Schwartz Journal: Arch Intern Med Date: 2008-05-12
Authors: H Kan; A R Folsom; M Cushman; K M Rose; W D Rosamond; D Liao; F Lurmann; S J London Journal: J Thromb Haemost Date: 2011-04 Impact factor: 5.824
Authors: Letizia Tarantini; Matteo Bonzini; Armando Tripodi; Laura Angelici; Francesco Nordio; Laura Cantone; Pietro Apostoli; Pier Alberto Bertazzi; Andrea A Baccarelli Journal: Occup Environ Med Date: 2013-03-08 Impact factor: 4.402
Authors: Sofia Pavanello; Matteo Bonzini; Laura Angelici; Valeria Motta; Laura Pergoli; Mirjam Hoxha; Laura Cantone; Angela Cecilia Pesatori; Pietro Apostoli; Armando Tripodi; Andrea Baccarelli; Valentina Bollati Journal: Toxicol Lett Date: 2016-08-06 Impact factor: 4.372
Authors: L Cantone; L Angelici; V Bollati; M Bonzini; P Apostoli; A Tripodi; P A Bertazzi; A A Baccarelli Journal: Environ Res Date: 2014-04-16 Impact factor: 6.498
Authors: Arunabh Talwar; Joe G N Garcia; Halley Tsai; Matthew Moreno; Tim Lahm; Roham T Zamanian; Roberto Machado; Steven M Kawut; Mona Selej; Stephen Mathai; Laura Hoyt D'Anna; Sonu Sahni; Erik J Rodriquez; Richard Channick; Karen Fagan; Michael Gray; Jessica Armstrong; Josanna Rodriguez Lopez; Vinicio de Jesus Perez Journal: Am J Respir Crit Care Med Date: 2017-10-15 Impact factor: 21.405